The Price of Pain: The Economic Burden of Migraine on the American Economy Capitol Hill Policy Forum
Payer Blocking Leaves Migraine Patients Behind
A new study led by the Headache & Migraine Policy Forum and recently published in the journal Headache quantifies the extent to which insurance barriers continue to limit access to effective migraine treatments. The study found that widespread “Payer Blocking,” whereby health plans delay and deny coverage for prescribed migraine therapies, severely disrupts care as the resulting misalignment between clinical guidelines and payer practices not only undermine patient outcomes but also increases costs across the health system.
Expanding the Treatment Toolbox for Migraine Pain
An Historic Investment in Female Servicemembers
“Time is Money” Takes on Telephonic Red Tape
“BioBonds” Could Revolutionize Funding for Medical Research
Preventing Migraine Can Improve Comorbid Conditions, Too
Headache Patients Go to Washington
One in six Americans suffers from recurrent headaches. Congress can help.
That was the message from hundreds of patient advocates who gathered at the U.S. Capitol for this year’s Headache on the Hill. People living with migraine and other headache disorders use the annual event to highlight legislative solutions that could improve their health care – and their lives.
A New First Line of Defense for Migraine
Headache experts have aligned on the best way to prevent migraine attacks. In newly updated guidance, the American Headache Society’s new position statement highlights CGRP inhibitors as the first-line approach to migraine prevention. First approved by the FDA in 2018, the medications can also reduce pain if they’re administered during a migraine attack.
Advocating for Migraine Treatment: A Focus on Insurance Barriers
A “how-to” toolkit on advocating for access to migraine treatment by removing insurance barriers.
